FDA 在信中引用了长期安全数据的“突出问题”。然而,Nymox 声称,在 3 月份提交申请之前,该机构在其任何一次交流中...查看全文
产业链观察2022-05-24 18:03
药闻▶2022年5月23日,$耐莫斯制药(NYMX)$ 今天报告说,它已于美国东部时间5月20日星期五下午2:48收到FDA关于公司的Fexapotide Triflutate新药申请("NDA")的拒绝提交("RTF")信。
Nymox的立场是,澄清问题仍需在后续会议上解决,并涉及一些重大的不一致之处。...查看全文
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-11-02,Director,Robinson James George ,买入,7000普通股, $1.98
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-11-01,Director,Robinson James George ,买入,6000普通股, $1.90
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-10-30,Director,Robinson James George ,买入,6000普通股, $1.78
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-10-31,Director,Robinson James George ,买入,12000普通股, $1.79
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-10-25,Director,Robinson James George ,买入,10000普通股, $1.62
$Nymox Pharmaceutical Corporation(NYMX)$ 内部交易: 2018-10-22,Director,Robinson James George ,买入,8000普通股, $1.67
$Nymox Pharmaceutical Corporation(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-13 AccNo: 0001640334-18-001545 Size: 1 MB 网页链接
$Nymox Pharmaceutical Corporation(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-15 AccNo: 0001640334-18-001003 Size: 1 MB 网页链接
$Nymox Pharmaceutical Corporation(NYMX)$ 20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Filed: 2018-05-11 AccNo: 0001640334-18-000936 Size: 920 KB 网页链接
$Nymox Pharmaceutical Corporation(NYMX)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-04-26 AccNo: 0001640334-18-000805 Size: 10 KB 网页链接